STRO
Sutro Biopharma
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
STRO fundamentals
Sutro Biopharma (STRO) expects to report earnings on Aug 12, 2025, with estimated revenue of 14.35M (YoY -44.18%), and EPS at -0.53 (YoY +10.17%).
Revenue estimate / YoY
14.35M
-44.18%
EPS estimate / YoY
-0.53
+10.17%
Report date
Aug 12, 2025
EPS
Revenue
Revenue & Expenses
STRO has released its 2025 Q1 earnings report, with revenue of 17.40M, reflecting a YoY change of 33.76%, and net profit of -75.97M, showing a YoY change of -30.50%. The Sankey diagram below clearly presents STRO's revenue sources and cost distribution.
Key Indicators
Sutro Biopharma (STRO) key financial stats and ratios, covering profitability, financial health, and leverage.
Sutro Biopharma (STRO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Sutro Biopharma (STRO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Sutro Biopharma (STRO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Sutro Biopharma (STRO) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Sutro Biopharma (STRO) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What guidance did Sutro Biopharma’s management provide for the next earnings period? What is the market’s earnings forecast for Sutro Biopharma next quarter?What is Sutro Biopharma’s gross profit margin?What is Sutro Biopharma’s latest dividend and current dividend yield?What factors drove the changes in Sutro Biopharma’s revenue and profit?What does Sutro Biopharma do and what are its main business segments?What is the revenue and EPS growth rate for Sutro Biopharma year over year?How were Sutro Biopharma’s latest financial results overall?